Inventor profile of:

Bruce A. Sullenger

City:

Durham, North Carolina

Country:

United States

Published Applications:

48

Last publication date:

2024-05-09

Top Assignees for applications by Bruce A. Sullenger

The entities that hold a legal rights for patent applications filed by inventor Sullenger Bruce A.:

Recent patent applications by Sullenger Bruce A.

Bruce A. Sullenger from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-09
US20240150772A1
Chemistry; metallurgy

Nucleolin-targeting aptamers and methods of using the same

#2 | 2023-10-19
US20230330271A1
Human necessities

THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME

#3 | 2023-08-10
US20230248805A1
Human necessities

INHIBITION OF ENDOSOMAL TOLL-LIKE RECEPTOR ACTIVATION

#4 | 2021-05-06
US20210129110A1
Performing operations; transporting

POLYCATIONIC MICROFIBERS AND METHODS OF USING THE SAME

#5 | 2021-01-21
US20210017497A1
Chemistry; metallurgy

Compositions and methods for cellular reprogramming

#6 | 2021-01-07
US20210000981A1
Human necessities

CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE

#7 | 2020-11-12
US20200353102A1
Human necessities

Thrombus imaging aptamers and methods of using same

#8 | 2020-09-10
US20200283773A1
Chemistry; metallurgy

Nucleolin-targeting aptamers and methods of using the same

#9 | 2020-04-09
US20200109404A1
Chemistry; metallurgy

Compositions and methods for differential induction of cell death and interferon expression

#10 | 2019-05-09
US20190136416A1
Textiles; paper

Electrospun cationic nanofibers and methods of making and using the same

#11 | 2018-11-08
US20180318454A1
Human necessities

CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE

#12 | 2018-11-08
US20180318337A1
Human necessities

POLYCATIONIC POLYMERS FOR USE IN TREATING AND DETECTING CANCER

#13 | 2018-07-19
US20180200183A1
Human necessities

2′ fluoro-modified RNAs as immunostimulators

#14 | 2018-05-03
US20180117182A1
Human necessities

Thrombus imaging aptamers and methods of using same

#15 | 2017-12-14
US20170355992A1
Chemistry; metallurgy

Factor V/Va-targeting aptamer compositions and methods of using the same

#16 | 2017-04-06
US20170095503A1
Human necessities

Inhibition of endosomal toll-like receptor activation

#17 | 2017-02-09
US20170037544A1
Textiles; paper

Electrospun cationic nanofibers and methods of making and using the same

#18 | 2016-10-06
US20160289297A1
Chemistry; metallurgy

Reversible platelet inhibition

#19 | 2016-09-01
US20160250165A1
Human necessities

Method of modulating the activity of a nucleic acid molecule

#20 | 2016-02-04
US20160030332A1
Human necessities

2-fluoro-modified RNAs as immunostimulators

#21 | 2015-11-12
US20150322425A1
Chemistry; metallurgy

RNA APTAMERS AND METHODS FOR IDENTIFYING THE SAME

#22 | 2014-09-18
US20140275226A1
Human necessities

Method of controlling coagulation

#23 | 2014-09-18
US20140275225A1
Chemistry; metallurgy

MODULATORS OF PHARMACOLOGICAL AGENTS

#24 | 2013-08-15
US20130210903A1
Human necessities

Aptamers to glycoprotein VI

#25 | 2012-10-18
US20120264815A1
Chemistry; metallurgy

Reversible platelet inhibition

#26 | 2012-07-19
US20120183564A1
Human necessities

Inhibition of endosomal toll-like receptor activation

#27 | 2012-07-12
US20120178917A1
Chemistry; metallurgy

RNA APTAMERS AND METHODS FOR IDENTIFYING THE SAME

#28 | 2012-05-17
US20120124683A1
Chemistry; metallurgy

Delivery method

#29 | 2012-04-05
US20120083521A1
Human necessities

Aptamers as agonists

#30 | 2011-08-11
US20110197292A1
Chemistry; metallurgy

Delivery method

#31 | 2011-06-30
US20110160443A1
Chemistry; metallurgy

RNA aptamers and methods for identifying the same

#32 | 2010-12-23
US20100324113A1
Chemistry; metallurgy

Delivery Method

#33 | 2010-11-11
US20100286228A1
Chemistry; metallurgy

Method of inhibiting intimal hyperplasia

#34 | 2010-10-21
US20100267802A1
Chemistry; metallurgy

DELIVERY METHOD

#35 | 2010-09-30
US20100249217A1
Chemistry; metallurgy

Modulators of pharmacological agents

#36 | 2010-07-22
US20100184822A1
Human necessities

Method of modulating the activity of a nucleic acid molecule

#37 | 2010-03-25
US20100076060A1
Human necessities

Aptamers as agonists

#38 | 2009-08-27
US20090215874A1
Chemistry; metallurgy

APTAMERS AS AGONISTS

#39 | 2009-06-25
US20090163429A1
Chemistry; metallurgy

RNA aptamers and methods for identifying the same

#40 | 2009-05-28
US20090136522A1
Chemistry; metallurgy

Multivalent Immunogen

#41 | 2008-09-11
US20080221053A1
Chemistry; metallurgy

RNA aptamers and methods for identifying the same

#42 | 2008-08-28
US20080207546A1
Chemistry; metallurgy

RNA aptamers and methods for identifying the same

#43 | 2008-08-21
US20080200413A1
Chemistry; metallurgy

RNA aptamers and methods for identifying the same

#44 | 2008-07-31
US20080182809A1
Chemistry; metallurgy

RNA aptamers and methods for identifying the same

#45 | 2008-02-28
US20080051339A1
Chemistry; metallurgy

Modulators of pharmacological agents

#46 | 2007-12-25
US9963827
-

RNA aptamers and methods for identifying the same

#47 | 2007-11-27
US10155233
-

Modulators of pharmacological agents

#48 | 2006-11-02
US20060246123A1
Chemistry; metallurgy

Oligonucleotide mimetics

InventorID:

391433 ⎘